The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 25% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (28 analysts) rates it buy, with a mean price target of $1197. It reported earnings in this window, a natural checkpoint for the thesis.
Equinix
EQIX · a US exchange · USD · Market cap $106.9B · 13,716 employees
Equinix, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-07-24
Screened 2026-07-24 · the tape above runs as of 22:40 UTC · 24 Jul · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Equinix holds its Markdown at $1,084.24. Consolidating, no directional conviction, held for 50 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 50 days |
| Price at the screen | $1,084.24 |
| Valuation | 74.93 trailing · 56.14 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 0.97 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 56.62% | Below 33% | Interest-bearing debt is 56.6% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 1.37% | Below 33% | Cash held in interest-bearing accounts and securities is 1.4% of assets, under the one-third limit. | Pass |
| Receivables | 6.80% | Below 49% | Money owed to the company is 6.8% of assets, under the 49% limit. | Pass |
| Revenue purity | 2.09% | Below 5% | Only 2.1% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades above our $759.51 fair value estimate, moderate competitive moat, 12.10% revenue growth.
Fair value range in USD, drawn from the 2026-07-24 screen. The gold marker is the market price at the same screen. The price runs 30.0% above the base estimate.
Third-party analyst targets: 29 covering, consensus Buy. The average target sits +12% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-07-24 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsData centre landlord charging more than it delivers
Picture the biggest cloud firms and banks needing a neutral meeting point for their servers. Equinix built that global handshake and still grows revenue at 12 percent a year. The trouble is the market already prices every future handshake at a 52.8 times forward multiple, well above our fair value.
We pass because the shares sit 26 percent above the level that would give a margin of safety and because the balance sheet fails our debt screen. A 15 percent profit margin and 10 percent return on equity do not justify stretching the valuation that far when leverage remains elevated.
Analyst targets sit higher still, yet the ethical flag on debt and the stretched multiple together outweigh the growth story. The business itself is solid infrastructure, just not at this price.
Analysis, not advice.
| Forward P/E | 56.1xexpensive even after accounting for its growth |
| Trailing P/E | 74.9xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 14.47 |
| EPS, forward | 19.31 |
| Revenue growth | +12.1%steady growth |
| Profit margin | 14.9%thin but positive margins |
| Return on equity | 10.1%a modest return on shareholder capital |
| FCF yield | 2.55% |
| Dividend yield | 184.00% |
| Debt to equity | 1.63a meaningful debt load worth watching |
| Current ratio | 1.18adequate liquidity, worth monitoring |
| Beta | 0.97steadier than the market |
| Short interest, float | 0.02% |
| 52-week range | 720.62 - 1,128.68 |
| Moat | MODERATE |
| Market cap | $106.9B |
| Employees | 13,716 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeEQIX trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 25% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (28 analysts) rates it buy, with a mean price target of $1197. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 25% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (28 analysts) rates it buy, with a mean price target of $1197. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 25% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 17%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (28 analysts) rates it buy, with a mean price target of $1197.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Equinix (EQIX) Advances While Market Declines: Some Information for Investors Zacks · 9d ago
- This Data Center IPO Is the Next Big Test for the AI Trade Barrons.com · 10d ago
- Oklo Just Dropped 28% in a Month. Is It Time to Abandon Nuclear Stocks Like OKLO, NuScale, and Uranium Energy Corp.? 24/7 Wall St. · 10d ago
- IREN Just Collapsed 41% in a Month: Is This Dead Money or an Abandoned Gem? 24/7 Wall St. · 10d ago
- Equinix (EQIX) Reshuffles Leadership, Is It Still 15% Below Fair Value? Simply Wall St. · 10d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | PAISLEY CHRISTOPHER B. | Director | 125 | $132,536 | |
| 2026-05-06 | MORANDI BRANDI GALVIN | Officer | 112 | · | |
| 2026-05-06 | MEYERS CHARLES JOHN | Director | 5,224 | $5,669,216 | |
| 2026-04-08 | MORANDI BRANDI GALVIN | Officer | 424 | $432,480 | |
| 2026-03-12 | LIN JONATHAN | Officer | 635 | $613,227 | |
| 2026-03-12 | PLETCHER KURT | Officer | 559 | $539,819 | |
| 2026-03-12 | PALADIN MICHAEL SHANE | Officer | 118 | $114,067 | |
| 2026-03-12 | MILLER SIMON | Officer | 289 | $279,096 | |
| 2026-03-12 | MORANDI BRANDI GALVIN | Officer | 630 | $605,550 | |
| 2026-03-12 | FOX-MARTIN ADAIRE | Chief Executive Officer | 1,086 | $1,049,295 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $1,080.87 | -4.0% | $5.16 | $965 | -3.5% |
| 2 months | $1,025.17 | +1.2% | $5.16 | $1,017 | +1.7% |
| 3 months | $966.69 | +7.4% | $5.16 | $1,079 | +7.9% |
| 6 months | $746.35 | +39.0% | $10.32 | $1,404 | +40.4% |
| 1 year | $887.16 | +17.0% | $19.70 | $1,192 | +19.2% |
| 2 years | $730.50 | +42.1% | $37.60 | $1,472 | +47.2% |
| 3 years | $698.04 | +48.7% | $53.79 | $1,564 | +56.4% |
| 5 years | $739.63 | +40.3% | $78.75 | $1,509 | +50.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever EQIX does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.